blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1534675

EP1534675 - FLUORO AND SULPHONYLAMINO CONTAINING 3,6-DISUBSTITUTED AZABICYCLO¬3.1.0 HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS [Right-click to bookmark this link]
Former [2005/22]FLUORO AND SULPHONYLAMINO CONTAINING 3,6-DISUBSTITUTED AZABICYCLO[3.1.0]HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS
[2007/46]
StatusNo opposition filed within time limit
Status updated on  01.01.2010
Database last updated on 29.07.2024
Most recent event   Tooltip15.08.2014Lapse of the patent in a contracting state
New state(s): GR		published on 17.09.2014  [2014/38]
Applicant(s)For all designated states
Ranbaxy Laboratories Limited
Plot No. 90, Sector - 32 Gurgaon 122 001
HR / IN
[N/P]
Former [2009/11]For all designated states
RANBAXY LABORATORIES, LTD.
Plot No. 90, Sector - 32 Gurgaon 122 001
HR / IN
Former [2005/22]For all designated states
RANBAXY LABORATORIES, LTD.
19, Nehru Place
New Delhi 110 019 / IN
Inventor(s)01 / MEHTA, Anita
L-19/3, DLF Qutab Enclave, Phase-II
Gurgaon, 122001 Haryana / IN
02 / GUPTA, Jang Bahadur
349, Sector-14, Gurgaon
122001 Haryana / IN
 [2005/22]
Representative(s)Cronin, Brian Harold John
CRONIN Intellectual Property Chemin de Précossy 31
1260 Nyon / CH
[N/P]
Former [2006/32]Cronin, Brian Harold John
Cronin Intellectual Property Route de Clémenty 62
1260 Nyon / CH
Former [2005/22]Gilholm, Stephen Philip
Ranbaxy Laboratories Ltd, 95 Park Lane
Mayfair, London W1K 7TE / GB
Application number, filing date02760461.023.08.2002
[2005/22]
WO2002IB03433
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004018422
Date:04.03.2004
Language:EN
[2004/10]
Type: A1 Application with search report 
No.:EP1534675
Date:01.06.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 04.03.2004 takes the place of the publication of the European patent application.
[2005/22]
Type: B1 Patent specification 
No.:EP1534675
Date:25.02.2009
Language:EN
[2009/09]
Search report(s)International search report - published on:EP04.03.2004
ClassificationIPC:C07D209/52, A61K31/40, A61P25/00
[2005/22]
CPC:
C07D209/94 (EP,US); A61P1/00 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P13/00 (EP); A61P13/02 (EP);
A61P25/00 (EP); A61P3/04 (EP); A61P3/10 (EP);
C07D209/52 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2005/22]
Extension statesAL23.03.2005
LT23.03.2005
LV23.03.2005
MK23.03.2005
RO23.03.2005
SI23.03.2005
TitleGerman:FLUOR- UND SULFONYLAMINOHALTIGE, 3,6-DISUBSTITUIERTE AZABICYCLO¬3.1.0 HEXANDERIVATE ALS MUSCARINREZEPTORANTAGONISTEN[2007/46]
English:FLUORO AND SULPHONYLAMINO CONTAINING 3,6-DISUBSTITUTED AZABICYCLO¬3.1.0 HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS[2007/46]
French:DERIVES D'AZABICYCLO(3.1.0)HEXANES 3,6-DISUBSTITUES CONTENANT FLUORO ET SULFONYLAMINO, UTILISES COMME ANTAGONISTES DES RECEPTEURS DE MUSCARINE[2005/22]
Former [2005/22]FLUOR- UND SULFONYLAMINOHALTIGE, 3,6-DISUBSTITUIERTE AZABICYCLO[3.1.0]HEXANDERIVATE ALS MUSCARINREZEPTORANTAGONISTEN
Former [2005/22]FLUORO AND SULPHONYLAMINO CONTAINING 3,6-DISUBSTITUTED AZABICYCLO[3.1.0]HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS
Entry into regional phase23.03.2005National basic fee paid 
23.03.2005Designation fee(s) paid 
23.03.2005Examination fee paid 
Examination procedure19.03.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
23.03.2005Examination requested  [2005/22]
16.06.2005Despatch of a communication from the examining division (Time limit: M06)
20.12.2005Reply to a communication from the examining division
28.04.2008Despatch of a communication from the examining division (Time limit: M04)
11.08.2008Reply to a communication from the examining division
19.09.2008Communication of intention to grant the patent
29.12.2008Fee for grant paid
29.12.2008Fee for publishing/printing paid
Opposition(s)26.11.2009No opposition filed within time limit [2010/05]
Fees paidRenewal fee
23.03.2005Renewal fee patent year 03
31.08.2005Renewal fee patent year 04
31.08.2006Renewal fee patent year 05
31.08.2007Renewal fee patent year 06
01.09.2008Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT25.02.2009
BE25.02.2009
CY25.02.2009
CZ25.02.2009
DK25.02.2009
EE25.02.2009
FI25.02.2009
GR25.02.2009
IT25.02.2009
NL25.02.2009
SK25.02.2009
TR25.02.2009
BG25.05.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
IE23.08.2009
LU23.08.2009
CH31.08.2009
LI31.08.2009
MC31.08.2009
[2014/38]
Former [2011/44]AT25.02.2009
BE25.02.2009
CY25.02.2009
CZ25.02.2009
DK25.02.2009
EE25.02.2009
FI25.02.2009
IT25.02.2009
NL25.02.2009
SK25.02.2009
TR25.02.2009
BG25.05.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
IE23.08.2009
LU23.08.2009
CH31.08.2009
LI31.08.2009
MC31.08.2009
Former [2011/21]AT25.02.2009
BE25.02.2009
CZ25.02.2009
DK25.02.2009
EE25.02.2009
FI25.02.2009
IT25.02.2009
NL25.02.2009
SK25.02.2009
BG25.05.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
IE23.08.2009
LU23.08.2009
CH31.08.2009
LI31.08.2009
MC31.08.2009
Former [2011/14]AT25.02.2009
BE25.02.2009
CZ25.02.2009
DK25.02.2009
EE25.02.2009
FI25.02.2009
IT25.02.2009
NL25.02.2009
SK25.02.2009
BG25.05.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
IE23.08.2009
CH31.08.2009
LI31.08.2009
MC31.08.2009
Former [2010/35]AT25.02.2009
BE25.02.2009
CZ25.02.2009
DK25.02.2009
EE25.02.2009
FI25.02.2009
NL25.02.2009
SK25.02.2009
BG25.05.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
IE23.08.2009
CH31.08.2009
LI31.08.2009
MC31.08.2009
Former [2010/21]AT25.02.2009
BE25.02.2009
CZ25.02.2009
DK25.02.2009
EE25.02.2009
FI25.02.2009
NL25.02.2009
SK25.02.2009
BG25.05.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
CH31.08.2009
LI31.08.2009
MC31.08.2009
Former [2010/16]AT25.02.2009
BE25.02.2009
CZ25.02.2009
DK25.02.2009
EE25.02.2009
FI25.02.2009
NL25.02.2009
SK25.02.2009
BG25.05.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
MC31.08.2009
Former [2010/08]AT25.02.2009
BE25.02.2009
CZ25.02.2009
DK25.02.2009
EE25.02.2009
FI25.02.2009
NL25.02.2009
SK25.02.2009
BG25.05.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
Former [2009/50]AT25.02.2009
BE25.02.2009
CZ25.02.2009
DK25.02.2009
EE25.02.2009
FI25.02.2009
NL25.02.2009
SK25.02.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
Former [2009/49]AT25.02.2009
BE25.02.2009
CZ25.02.2009
DK25.02.2009
EE25.02.2009
FI25.02.2009
NL25.02.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
Former [2009/46]AT25.02.2009
BE25.02.2009
DK25.02.2009
FI25.02.2009
NL25.02.2009
SE25.05.2009
ES05.06.2009
Former [2009/43]AT25.02.2009
BE25.02.2009
FI25.02.2009
NL25.02.2009
SE25.05.2009
Former [2009/40]AT25.02.2009
FI25.02.2009
NL25.02.2009
SE25.05.2009
Former [2009/38]FI25.02.2009
NL25.02.2009
SE25.05.2009
Former [2009/34]NL25.02.2009
Cited inInternational search[A]US5397800  (ALKER DAVID [GB], et al) [A] 1-54* column 1, line 6 - line 9; claims 1-6 *;
 [A]WO9515312  (BASF AG [DE], et al) [A] 1-54 * page 5, line 25; claims 1,2 *;
 [A]WO9515327  (BASF AG [DE], et al) [A] 1-54 * page 5, line 2; claims 1,2 *;
 [A]WO9736906  (NOVO NORDISK AS [DK]) [A] 1-54 * claims 1-25 *;
 [A]US5735690  (MALENTACCA AUGUSTO [IT]) [A] 1-54 * claims 1-3 *;
 [A]  - L. JEPPESEN ET AL., "1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2.6)]heptanes as New Potent Muscarinic M1 Agonists: Structure-Activity Relationship for 3-Aryl-2-propyn-1-yloxy and 3-Aryl-2-propin-1-ylthio Derivatives", J. MED. CHEM., (1999), vol. 42, no. 11, pages 1999 - 2006, XP002218716 [A] 1-54 * table 1 *

DOI:   http://dx.doi.org/10.1021/jm9910019
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.